Literature DB >> 3950935

Early prenatal investigation of a pregnancy at risk of adenosine deaminase deficiency using chorionic villi.

D A Aitken, D H Gilmore, C A Frew, M E Ferguson-Smith, M J Carty, W R Chatfield.   

Abstract

A pregnancy at risk for adenosine deaminase deficiency and severe combined immunodeficiency disease was investigated using samples of chorionic villi obtained during the eighth week of pregnancy. Adenosine deaminase levels suggested that the fetus was a probable carrier and that a diagnosis of severe combined immunodeficiency disease could be excluded. Enzyme and chromosome results were available within 24 hours of the chorionic villous sampling procedure, and were confirmed on amniotic fluid cell cultures after amniocentesis at 17 weeks' gestation and on cord blood at delivery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950935      PMCID: PMC1049541          DOI: 10.1136/jmg.23.1.52

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  First trimester diagnosis of Hunter syndrome on chorionic villi.

Authors:  W J Kleijer; O P van Diggelen; H C Janse; H Galjaard; Y Dumez; J Boué
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

Review 3.  Prenatal diagnosis of immunodeficiency disorders.

Authors:  D C Linch; R J Levinsky
Journal:  Br Med Bull       Date:  1983-10       Impact factor: 4.291

4.  Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.

Authors:  D C Linch; R J Levinsky; C H Rodeck; K A Maclennan; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

5.  Adenosine-deaminase deficiency in a child diagnosed prenatally.

Authors:  R Hirschhorn; N Beratis; F S Rosen; R Parkman; R Stern; S Polmar
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.